Substance Use Module
Substance Use Module
INTRODUCTION
Addiction psychiatry is a subspecialty within the field of psychiatry that focuses on the
evaluation, diagnosis, and treatment of individuals suffering from substance use disorders
(SUDs) and related behavioral addictions. It plays a vital role in understanding the
psychological, neurobiological, and social aspects of addiction, offering comprehensive
care for patients struggling with the misuse of substances such as alcohol, nicotine,
opioids, cannabis, stimulants, and sedatives. These substances can alter brain chemistry
and behavior, often leading to compulsive use despite harmful consequences.
Substance use typically begins voluntarily, often influenced by environmental factors,
peer pressure, emotional distress, or genetic vulnerability. However, repeated use can
lead to tolerance, dependence, and addiction—a chronic, relapsing condition
characterized by impaired control over substance use, craving, and continued use despite
negative outcomes. Addiction psychiatry also addresses the high rates of psychiatric
comorbidities associated with substance use, including depression, anxiety, bipolar
disorder, and schizophrenia. These co-occurring conditions require integrated treatment
approaches for effective recovery.
Treatment in addiction psychiatry is multifaceted, involving a combination of
pharmacological interventions (such as methadone, buprenorphine, or naltrexone for
opioid use disorder), evidence-based psychotherapies (including cognitive behavioral
therapy and motivational interviewing), and psychosocial support systems (like group
therapy and 12-step programs). Prevention and relapse management are also key areas,
focusing on long-term recovery and improving quality of life.
Addiction psychiatry plays a critical role in reducing the stigma surrounding substance
use and ensuring that individuals receive compassionate, individualized care. As
substance use continues to be a major public health issue globally, addiction psychiatry
remains essential in guiding both clinical practice and public policy toward effective
solutions.
OBJECTIVES
On completion of this module, the students will be able to
7. Apply nursing process its caring for patients with substance related
disorders
[Link] Intoxication
Substance intoxication is a reversible, substance-specific condition that occurs shortly
after the recent use or exposure to a psychoactive substance. It involves clinically
significant behavioral or psychological changes, such as impaired judgment, mood shifts,
motor incoordination, or altered perception, which are directly caused by the effects of
the substance on the central nervous system. The specific symptoms depend on the type
and amount of substance used. For example, alcohol intoxication may result in slurred
speech, unsteady gait, or euphoria, while stimulant intoxication, such as from cocaine or
amphetamines, can cause increased energy, restlessness, or paranoia. Substance
intoxication is typically acute and short-term, but in some cases, it can lead to harmful
consequences like accidents, aggression, overdose, or other medical emergencies. It is
recognized as a distinct diagnostic category in psychiatric classifications such as the
DSM-5 and applies to various substances, including alcohol, opioids, cannabis, sedatives,
stimulants, hallucinogens, and inhalants.
[Link] Use Disorder
Substance Use Disorder (SUD) is a clinical term used to describe a pattern of substance
use that leads to significant impairment or distress. According to the DSM-5, it is
diagnosed when at least two or more criteria are met within a 12-month period, including
craving, tolerance, withdrawal, loss of control, failed obligations, and continued use
despite harm. SUD can range in severity: mild (2–3 criteria), moderate (4–5), or severe (6
or more). It reflects both physical and psychological dependence on a substance and can
involve drugs like alcohol, opioids, stimulants, cannabis, sedatives, or tobacco. The term
encompasses what was previously referred to as "substance abuse" and "substance
dependence," combining them into a single, more flexible diagnosis to better capture the
continuum of addiction.
[Link] withdrawal
Substance withdrawal is a physiological and psychological reaction that occurs when a
person who has developed dependence on a substance suddenly reduces or stops using it.
It results from the body adapting to the presence of the drug over time, leading to an
imbalance when the substance is removed. The symptoms and severity of withdrawal
vary depending on the type of substance used, the duration and amount of use, and
individual health factors. Common withdrawal symptoms may include anxiety,
irritability, sweating, tremors, nausea, insomnia, and, in some cases, more severe effects
like seizures or hallucinations. For example, alcohol withdrawal can lead to tremors,
agitation, and in severe cases, delirium tremens, while opioid withdrawal may cause
muscle aches, diarrhea, and restlessness. Withdrawal is a clinically significant condition
and is included as a diagnosis in the DSM-5 for most substance classes. Management
often requires medical supervision, especially in cases involving alcohol,
benzodiazepines, or opioids, and may include medications to relieve symptoms and
support recovery.
[Link] Drinking
Heavy drinking refers to the consumption of alcohol in large quantities that exceed
recommended health guidelines. It is often defined by frequency and volume, such as
more than 14 drinks per week for men or more than 7 for women. This pattern increases
the risk of health problems including liver disease, heart issues, and mental health
disorders. Heavy drinking can impair judgment and increase the risk of accidents and
injuries. Over time, it may lead to the development of alcohol use disorder.
[Link]
Dependence is a condition where the body or mind becomes accustomed to regular
substance use, making it difficult to function without it. It can be physical, with
withdrawal symptoms occurring when use is stopped, or psychological, where there is an
emotional need to continue use. Dependence often develops gradually through repeated
exposure to a substance. It signifies a deeper stage of substance use, often requiring
professional treatment. Dependence can exist with or without addiction.
[Link]
Tolerance occurs when a person needs increasing amounts of a substance to achieve the
same effect previously experienced with smaller doses. It develops as the brain and body
adapt to the continued presence of the substance. This can lead to higher consumption,
which increases the risk of overdose and long-term health damage. Tolerance is a key
indicator of developing dependence or addiction. It can happen with many substances,
including alcohol, opioids, and stimulants.
[Link]
Remission refers to a period in which the symptoms of a substance use disorder are
reduced or no longer present. It can be classified as early remission (less than 12 months)
or sustained remission (12 months or more without symptoms). While in remission,
individuals may still be at risk for relapse, especially when exposed to triggers.
Continued support and treatment are often necessary to maintain remission. It indicates
progress but not necessarily a permanent recovery.
[Link]
Craving is a strong, often overwhelming urge or desire to use a substance. It can be
triggered by internal states like stress or external cues such as places, people, or objects
associated with past use. Craving is a key feature of substance use disorders and
contributes to the risk of relapse. It is driven by changes in the brain’s reward and
memory circuits. Managing cravings is a crucial part of addiction treatment and relapse
prevention.
[Link]
Detoxification, or detox, is the medical process of safely eliminating a substance from the
body. It is typically the first step in treating substance dependence and focuses on
managing withdrawal symptoms. Detox can take place in inpatient or outpatient settings
depending on the substance and severity of dependence. Medical supervision is often
necessary, especially for substances like alcohol or benzodiazepines. Detox alone does
not treat addiction but prepares individuals for further therapy.
[Link]
Harm reduction is a public health approach aimed at minimizing the negative
consequences of substance use without necessarily requiring abstinence. It includes
strategies like needle exchange programs, supervised injection sites, and distribution of
naloxone to prevent overdoses. The focus is on safety, health, and dignity rather than
punishment or stigma. Harm reduction meets individuals where they are in their
substance use journey. It is often used alongside other treatment methods.
[Link]
A substance is any chemical or drug that, when taken into the body, can alter physical or
mental functioning. Substances may be legal, such as alcohol, tobacco, and prescription
medications, or illegal, such as heroin and cocaine. In the context of psychiatry, the term
often refers to psychoactive substances that affect the central nervous system. Substances
can lead to dependence, intoxication, withdrawal, and other mental or behavioral
disorders. Repeated or excessive use increases the risk of developing a substance use
disorder.
[Link](AUD)
Alcohol Use Disorder is a chronic condition characterized by a problematic pattern of
alcohol consumption leading to significant impairment or distress. It includes symptoms
such as craving, loss of control over drinking, tolerance, withdrawal, and continued use
despite harm. AUD ranges from mild to severe depending on the number of criteria met
in the DSM-5. It can cause serious physical, psychological, and social consequences.
Treatment typically includes behavioral therapies, medications like naltrexone or
acamprosate, and support groups.
[Link]
Cannabis Use Disorder involves the frequent or heavy use of cannabis that results in
significant problems in daily functioning. Individuals may experience cravings, tolerance,
withdrawal symptoms like irritability or sleep problems, and unsuccessful efforts to cut
down. Chronic use can impair memory, concentration, and motivation, and may increase
the risk of psychosis in vulnerable individuals. It is diagnosed based on DSM-5 criteria,
similar to other substance use disorders. Treatment may include cognitive behavioral
therapy and motivational enhancement.
[Link] Disorder
Stimulant Use Disorder is a condition marked by the compulsive use of stimulant drugs
such as cocaine, amphetamines, or methamphetamine. It leads to significant mental,
emotional, and physical impairments, including paranoia, agitation, insomnia, and
cardiovascular issues. Users often build tolerance quickly and may binge on the drug,
increasing the risk of overdose and psychosis. Diagnosis is based on behavioral patterns
and negative impacts on functioning. Treatment includes behavioral therapies, but there
are currently no approved medications for this disorder.
[Link] Use Disorder(OUD)
Opioid Use Disorder is a chronic and potentially life-threatening condition involving the
misuse of opioids such as heroin, morphine, or prescription pain relievers like
oxycodone. It is characterized by intense cravings, tolerance, withdrawal symptoms, and
continued use despite harm. OUD often leads to social, legal, and health problems,
including a
CLASSIFICATION OF PSYCHOACTIVE SUBSTANCES
The classification of psychoactive substances can be understood in detail by examining
various factors such as their effects on the central nervous system, legal status, origin,
potential for dependence, and intended use.
Based on central nervous system
1. Depressants
Effect: These substances reduce CNS activity, leading to sedation, relaxation, reduced
anxiety, and slowed bodily functions.
Examples:
Alcohol – commonly used depressant that impairs coordination
and judgment.
Benzodiazepines (e.g., diazepam, lorazepam) – used medically
for anxiety and insomnia.
Barbiturates – older class of sedatives now less commonly used
due to overdose risk.
2. Stimulants
Effect: These increase CNS activity, resulting in heightened alertness, energy, improved
mood, and increased heart rate.
Examples:
Cocaine – powerful stimulant that produces intense euphoria.
Amphetamines (e.g., Adderall, methamphetamine) – used for
ADHD and narcolepsy but often misused.
Caffeine and Nicotine – legal and commonly consumed
stimulants with milder effects.
3. Opioids
Effect: These act on opioid receptors to relieve pain and produce euphoria, relaxation,
and drowsiness.
Examples:
Heroin – illegal and highly addictive opioid.
Morphine and Codeine – used in medicine for pain relief.
Fentanyl – synthetic opioid with high potency, often involved in
overdose deaths.
4. Cannabinoids
Effect: These affect mood, memory, appetite, and perception by interacting with the
endocannabinoid system.
Examples:
Cannabis (marijuana) – contains THC, which causes euphoria
and altered perception.
Synthetic cannabinoids (e.g., Spice, K2) – often more potent
and unpredictable than natural cannabis.
5. Hallucinogens
Effect: These cause profound distortions in perception, mood, and thought; often
associated with visual or auditory hallucinations.
Examples:
LSD (lysergic acid diethylamide) – potent hallucinogen with
long-lasting effects.
Psilocybin – found in "magic mushrooms," alters perception and
awareness.
Mescaline – derived from the peyote cactus, used in some
indigenous rituals.
6. Dissociatives
Effect: These induce a feeling of detachment from the environment and self, sometimes
causing hallucinations.
Examples:
Ketamine – used medically as an anesthetic and also misused
recreationally.
Phencyclidine (PCP) – known for strong dissociative and
hallucinogenic effects.
Dextromethorphan (DXM) – found in cough suppressants; high
doses can cause dissociation.
7. Inhalants
Effect: These are volatile substances that produce quick, short-lasting effects such as
dizziness, euphoria, and altered mental state.
Examples:
Solvents (e.g., glue, paint thinner)
Nitrous oxide (“laughing gas”) – used medically and
recreationally
Aerosols and fuels – household products inhaled for their
intoxicating effects
Based on legal definition
Legal definitions of psychoactive substances based on
"schedules", as used in many countries’ drug control laws (e.g., the
U.S. Controlled Substances Act, India’s NDPS Act, or the UN drug
control conventions):
Drugs are classified into "Schedules" based on:
Their medical use
Potential for abuse
Risk of dependence
Although specifics vary by country, the general principles are similar:
Schedule I (or Schedule H, Group A – varies by country)
Definition:
High abuse potential
No accepted medical use in many countries
Not considered safe even under medical supervision
Examples:
Heroin
LSD (lysergic acid diethylamide)
MDMA (Ecstasy)
Cannabis (in some jurisdictions)
Implication:
Illegal to manufacture, possess, or distribute.
Severe legal penalties.
Schedule II
Definition:
High potential for abuse, but
Accepted medical use with severe restrictions
Abuse may lead to severe physical or psychological
dependence
Examples:
Cocaine (used in local anesthesia)
Methadone (for opioid dependence treatment)
Morphine
Amphetamines
Implication:
Can be prescribed by licensed doctors under strict controls.
Heavily regulated manufacturing and storage.
Schedule III
Definition:
Moderate to low potential for abuse
Accepted medical use
Risk of moderate or low physical dependence
Examples:
Buprenorphine
Ketamine
Anabolic steroids
Some barbiturates
Implication:
Prescribable with fewer restrictions than Schedule II drugs.
Schedule IV
Definition:
Lower abuse potential
Accepted medical uses
Limited risk of dependence
Examples:
Benzodiazepines (e.g., diazepam, alprazolam)
Zolpidem (sleep aid)
Clonazepam
Implication:
Available by prescription, often with fewer monitoring
requirements.
Schedule V
Definition:
Lowest potential for abuse
Widely accepted medical uses
Contain limited quantities of certain narcotics
Examples:
Cough syrups with codeine
Loperamide
Diphenoxylate with atropine
Implication:
Often available without prescription in limited quantities in some
countries.
2. Semi-Synthetic Substances
Definition: These are chemically modified substances derived from natural sources.
They combine elements of both natural and synthetic compounds.
Examples:
Heroin – synthesized from morphine (which is extracted from
opium).
LSD (Lysergic acid diethylamide) – derived from ergot fungus
found on rye.
Cocaine hydrochloride – purified and processed from natural
coca leaves.
Buprenorphine – modified opioid derived from thebaine (an
opiate alkaloid).
Key Points:
Often more potent or fast-acting than the natural substance.
Common in pharmaceutical and illicit drug production.
3. Synthetic Substances
Definition: These substances are entirely man-made in laboratories using chemical
synthesis and do not exist in nature.
Examples:
Methamphetamine – powerful synthetic stimulant.
MDMA (Ecstasy) – synthetic drug with stimulant and
hallucinogenic effects.
Fentanyl – synthetic opioid with high potency, used in medicine
and illicit markets.
Synthetic cannabinoids – lab-made compounds mimicking THC
(e.g., Spice, K2).
Synthetic cathinones – often known as "bath salts", mimic
stimulant effects.
Based on use or clinical utility
1. Therapeutic Drugs
Definition: These psychoactive substances are used medically for treating various
conditions such as pain, anxiety, sleep disorders, attention deficits, or substance use
disorders.
Examples:
Morphine, oxycodone – used for pain relief (opioids).
Diazepam, lorazepam – used to manage anxiety or seizures
(benzodiazepines).
Methylphenidate, amphetamines – used for ADHD and
narcolepsy (stimulants).
Methadone, buprenorphine – used in opioid substitution
therapy.
Require a medical prescription.
Risk of dependence if misused.
Closely monitored in clinical settings
2. Recreational Drugs
Definition: These substances are used non-medically, typically for pleasure, relaxation,
euphoria, or social purposes. They often affect mood, perception, or consciousness.
Examples:
Alcohol – consumed socially for relaxation and intoxication.
Cannabis – used for mood enhancement or altered perception.
Ecstasy (MDMA) – used recreationally for euphoric and
empathogenic effects.
Cocaine, heroin – used illicitly for their intense effects, though
with high abuse potential.
Often associated with misuse and legal restrictions.
Can lead to dependence and health consequences.
Some are decriminalized or legalized in specific regions.
3. Ritualistic/Spiritual Use
Definition: These substances are used in religious, cultural, or spiritual practices,
often to induce altered states of consciousness or facilitate connection with the divine.
Examples:
Ayahuasca – a brew containing DMT, used in Amazonian spiritual
ceremonies.
Peyote (mescaline) – used in Native American religious rites.
Psilocybin mushrooms – used in traditional healing and spiritual
contexts.
Usage is often protected or regulated under religious freedom
laws.
Effects are typically hallucinogenic and introspective.
Increasing interest in clinical use for mental health under
controlled conditions.
[Link]
The psychological model focuses on the emotional, cognitive, and behavioral aspects of
addiction. It considers substance use as a maladaptive way to cope with psychological
stress, trauma, or unresolved internal conflicts. This model supports therapeutic
interventions such as Cognitive Behavioral Therapy (CBT), which helps individuals
recognize and change harmful thought patterns and behaviors, and Motivational
Interviewing (MI), which enhances internal motivation to quit. Other techniques like
contingency management use reward-based systems to reinforce sobriety and healthy
behaviors.
[Link]
The biopsychosocial model integrates biological, psychological, and social dimensions of
substance use. It recognizes that no single factor is responsible for addiction; instead, it
results from the complex interaction between genetic vulnerability, mental health,
environmental influences, and social conditions. Treatment within this framework is
holistic, addressing physical health, emotional well-being, cognitive distortions, family
dynamics, peer relationships, and social functioning. It supports a team-based approach
including medical professionals, therapists, social workers, and peer support.
[Link]
The sociocultural model emphasizes the influence of society, culture, and interpersonal
relationships on substance use behavior. It considers factors such as peer pressure,
cultural norms, family environment, and socioeconomic status in both the development
and recovery from addiction. Treatment based on this model focuses on strengthening
social support systems, community engagement, peer group interventions, and family
therapy. It highlights the importance of addressing systemic issues and building a
supportive environment that promotes healthy behaviors.
[Link]
The moral and spiritual model sees addiction as a failure of moral integrity or spiritual
alignment, often linked to a loss of purpose or ethical values. It promotes the idea that
recovery involves personal responsibility, moral reformation, and spiritual growth. This
approach is exemplified in 12-step programs such as Alcoholics Anonymous (AA),
where individuals are encouraged to admit powerlessness over the substance, seek help
from a higher power, make amends, and support others in recovery. Spiritual practices,
accountability, and peer support are central to this model.
[Link]
The integrated or multimodal approach combines elements from various models to create
a personalized treatment plan. It acknowledges the complexity of addiction and tailors
interventions to the individual's medical, psychological, social, and spiritual needs. For
example, a person may receive medical detoxification, psychotherapy, social support, and
engage in a spiritual recovery group simultaneously. This model is considered most
effective, especially for individuals with dual diagnoses or long-standing substance use
disorders, as it provides comprehensive and flexible care.
C) . Diagnosis
Purpose:
Diagnosis is the formal identification of a substance use disorder based on standardized criteria,
typically from the Diagnostic and Statistical Manual of Mental Disorders (DSM-5-TR) or ICD-11.
DSM-5CriteriaforSUD:
A diagnosis is made if a person meets at least 2 of the following 11 criteria within a 12-month period,
categorized into four groups:
Impaired Control:
o Substance taken in larger amounts or over longer periods than
intended.
o Persistent desire or unsuccessful efforts to cut down.
o A great deal of time spent obtaining, using, or recovering from use.
o Craving or strong desire to use.
Social Impairment:
o Failure to fulfill major obligations at work, school, or home.
o Continued use despite persistent social or interpersonal problems.
o Important activities reduced or given up due to use.
Risky Use:
o Recurrent use in physically hazardous situations.
o Continued use despite knowing it causes physical or psychological
harm.
Pharmacological Criteria:
o Tolerance (need more to get same effect).
o Withdrawal (specific symptoms when not using).
Severity Classification:
Mild: 2–3 symptoms
Moderate: 4–5 symptoms
Severe: 6 or more symptoms
The diagnosis may also specify the substance involved (e.g., opioid use disorder, cannabis use disorder),
the stage (e.g., in early or sustained remission), and whether the disorder is accompanied by
physiological dependence.
Cognitive-Behavioral Therapy (CBT)
Cognitive-behavioral therapy, abbreviated as CBT, is a type of psychotherapy.
This conversational approach involves structured one-on-one sessions with a
mental health counselor. CBT therapists aim to reshape patients’ negative
thoughts: a change that empowers those in recovery to meet life's challenges.
CBT can be a very effective treatment for mental disorders and addiction, either
alone or in combination with other therapies. It helps those in early recovery to
manage symptoms, prevent relapse, learn coping mechanisms, and overcome
emotional trauma.1 Through a goal-oriented approach, CBT participants will
discuss thoughts and feelings with their therapists. Sessions cover topics like
resilience, stress management, assertiveness, and relaxation.
Counseling: Individual and Group
Counseling can take place in individual or group settings.
*Individual Counseling: By speaking with a licensed counselor on a one-on-one
basis, a person in recovery can gain a better understanding of their addiction and
the factors contributing to it. This approach is also called “talk therapy.”
*Group Counseling: In group therapy, recovering individuals share their stories
and learn from the experiences of others, decreasing feelings of loneliness and
isolation common to active addiction. These meetings are sometimes called
“process groups.”
Dialectical Behavioral Therapy (DBT)
Developed in the 1980s as a treatment for borderline personality disorder,
dialectical behavior therapy is a type of CBT focused on behavioral skill
development. These lessons equip participants with in-the-moment tools to
manage emotions, improve relationships, resolve conflict, and handle stress.
Outcomes data indicates that DBT successfully treats addiction and various
mental health diagnoses.2
Through individual therapy sessions and group education, dialectical behavior
therapy promotes skill-building in four key areas.
1. Mindfulness – Accepting and being present in the moment.
2. Distress Tolerance – Coping with negative feelings rather than seeking to
escape them.
3. Emotion Regulation – Learning to manage and change intense,
problematic emotions.
4. Interpersonal Effectiveness – Becoming more assertive and prioritizing self-
respect.
Experiential Therapy
When most people picture addiction treatment, they think of traditional talk
therapy: a series of conversations spread over several sessions. However,
hands-on learning can also be a powerful tool for those in early recovery.
Experiential therapy is effective for the treatment of substance use disorders
because it deeply engages the patient’s emotions. Participants explore
subconscious thoughts and feelings through guided imagery, role-playing, and
other activities. In this way, people who cannot articulate complex emotions (or
convey the details of their trauma) may begin processing them.
Examples of experiential therapy include:
Art therapy
Music therapy
Equine therapy and other animal-assisted therapies
Creative writing or poetry therapy
Adventure therapy (wilderness expeditions, ropes courses, ziplining)
Play therapy
Drama therapy (psychodrama)
MANAGEMENT
Treatment and prevention of problematic technology use can involve a range of
approaches. A first step is assessment and counseling from a mental
health professional. Cognitive-behavioral therapy (CBT) is commonly
used to address the underlying psychological factors contributing to
addiction. Therapy may focus on helping the individual increase their
awareness and understanding of their behaviors and develop healthy
coping mechanisms and positive behaviors. Mindfulness techniques
and motivational interviewing can also be useful.
Nursing Diagnosis
Based on the assessment data, the major nursing
diagnosis for substance abuse are:
Nursing Interventions
1. Physical/Medical Interventions
Monitor vital signs regularly to detect signs of intoxication or withdrawal
(e.g., tachycardia, hypertension, tremors, seizures).
Manage withdrawal symptoms by administering medications as
prescribed (e.g., benzodiazepines for alcohol withdrawal, methadone or
buprenorphine for opioid dependence).
Ensure hydration and nutrition, especially if the patient is malnourished
or dehydrated due to substance use.
Provide a safe environment by removing harmful objects, minimizing
stimulation, and using fall precautions if the patient is disoriented.
Address comorbid conditions, such as liver disease (alcohol), respiratory
depression (opioids), or infections (from IV drug use).
Administer vitamins/supplements like thiamine and folic acid to prevent
complications like Wernicke’s encephalopathy in alcohol use.
2. Psychological/Emotional Interventions
Establish trust through a nonjudgmental and empathetic
attitude; maintain confidentiality and respect patient dignity.
Conduct frequent mental status evaluations to assess mood,
cognition, and suicidality, especially during withdrawal or detox.
Use therapeutic communication techniques to encourage
the patient to verbalize feelings, guilt, anger, or fear related to
substance use.
Help manage cravings and triggers by identifying high-risk
situations and teaching self-soothing and coping techniques.
Reinforce motivation using techniques from motivational
interviewing (MI) to explore ambivalence and enhance
commitment to change.
3. Educational Interventions
Educate about the effects of substances on physical and
mental health, as well as the risks of overdose and unsafe
behaviors.
Explain the nature of dependence and how tolerance,
withdrawal, and relapse work as part of the disease process.
Provide information on medications used in treatment (e.g.,
naltrexone, acamprosate, disulfiram), including benefits and side
effects.
Instruct on relapse prevention strategies, including stress
management, avoiding triggers, and seeking help when
struggling.
Teach about harm reduction methods (if abstinence isn’t
immediately possible), such as using clean needles or safe alcohol
limits.
4. Social and Behavioral Interventions
Encourage participation in group therapy or peer support
groups (like Alcoholics Anonymous or Narcotics Anonymous).
Engage family members, if appropriate, in therapy and
education to build support systems and improve communication.
Assist with social reintegration by referring to vocational
training, legal aid, housing assistance, or rehabilitation services.
Promote healthy routines by helping the patient establish a
daily schedule with time for rest, physical activity, and hobbies.
Facilitate follow-up care by arranging referrals to outpatient
treatment programs, counseling, or community recovery centers.
5. Crisis and Emergency Interventions
Respond promptly to overdose or acute intoxication by
initiating emergency protocols, administering antidotes (e.g.,
naloxone for opioids), and stabilizing the patient.
Manage aggression or psychosis by using de-escalation
techniques and, if necessary, medication or seclusion (as per
legal and ethical guidelines).
The client was able to abstain from alcohol and drug use.
The client was able to express feelings openly and directly.
The client was able to verbalize acceptance of responsibility for
his or her own behavior.
The client was able to practice nonchemical alternatives to deal
with stress or difficult situations.
The client was able to establish an effective after-care plan.
Documentation Guidelines
Documentation in a client with substance abuse disorders includes:
REHABILITATION ISSUES
Rehabilitation for individuals recovering from substance use disorders involves more
than just achieving abstinence—it requires addressing a broad set of psychological,
social, medical, and economic challenges. One significant issue is the persistent stigma
attached to substance use, which often leads to social exclusion, reduced opportunities,
and internalized shame, all of which can undermine recovery efforts. Mental health
comorbidities such as depression, anxiety, PTSD, or personality disorders are also
common and, if left untreated, can contribute to relapse or poor functioning. Motivation
for recovery can fluctuate, especially in involuntary admissions or among individuals
with low insight into their condition, which complicates long-term engagement in
treatment programs.
Another major concern is the fragmentation of care—many rehabilitation
programs fail to coordinate between detox, therapy, aftercare, and social
reintegration services. This gap increases the likelihood of relapse, particularly
when support systems are weak. Economic issues, such as unemployment or
financial instability, further limit recovery as many individuals may lack the
resources to access treatment or rebuild their lives. The absence of skill
development or vocational training in some rehabilitation centers means that
patients leave treatment unequipped for the workforce, which contributes to
recidivism.
Family dysfunction and lack of supportive home environments also pose major
obstacles. Many individuals return to households where substance use is still
prevalent or where relationships remain strained. Additionally, legal problems
stemming from past substance use (e.g., criminal records) can limit access to
housing, education, and employment. The lack of long-term follow-up care, peer
support groups, or structured aftercare plans contributes to a revolving-door pattern
of relapse and readmission.
CONCLUSION
Substance use disorder is a significant public health concern that affects individuals
across all age groups and backgrounds. It involves a compulsive pattern of substance use
despite harmful consequences, often rooted in a combination of genetic, psychological,
social, and environmental factors. Understanding the classification of psychoactive
substances—based on their effects, origin, legal status, and potential for dependence—is
essential for accurate diagnosis and tailored treatment planning.
Effective management of substance use disorders requires a comprehensive approach
involving medical detoxification, psychosocial therapies, relapse prevention strategies,
and long-term rehabilitation. Nursing management plays a pivotal role in assessment,
therapeutic communication, patient education, medication administration, and ongoing
support throughout the recovery journey. Ethical and legal considerations must also be
upheld to ensure patient rights, safety, and dignity are respected.
Rehabilitation involves addressing not only the physical and psychological impact of
substance use but also the broader social and functional issues such as stigma,
reintegration, and vocational challenges. A coordinated, patient-centered approach,
supported by family, community, and healthcare providers, enhances the chances of
sustained recovery.
REFERENCE
[Link] Psychiatric Association. (2013). Diagnostic and Statistical Manual of Mental
Disorders (5th ed.). Arlington, VA: American Psychiatric Publishing.
[Link] Health Organization. (2004). Neuroscience of psychoactive substance use and
dependence. Geneva: WHO Pre
[Link]://[Link]/health/diseases/16652-drug-addiction-substance-use-
disorder-sud